Emerging treatments
Panobinostat PK/PD profile in combination with bortezomib and dexamethasone in patients with relapsed and relapsed/refractory multiple myeloma. Mu S et al. Eur J Clin Pharmacol. 2015 Oct 22. [Epub ahead of print]. Panobinostat for the treatment of multiple myeloma: the evidence to date. Bailey H et al. J Blood Med. 2015 Oct 8;6:269-76. doi: 10.2147/JBM.S69140. eCollection 2015. Panobinostat for the treatment of relapsed…